Author

Mallory Factor

University of Oxford

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1

Frequent Co-Authors

Antony GalioneiD· 2 shared Frances M. PlattiD· 2 shared Grant C. ChurchilliD· 2 shared Lianne C. DavisiD· 2 shared Marc C. PattersoniD· 2 shared Michael Leo StruppiD· 2 shared Taylor FieldsiD· 2 shared Rebecca Brain· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

9 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

Antony GalioneORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

N-acetyl-L-leucine (Levacetylleucine) normalizes Transcription Factor EB (TFEB) activity by stereospecific bidirectional modulation

Lianne C. Davis, Rebecca Braine, Grant C. Churchill, Mallory Factor, Taylor Fields, Marc C. Patterson, Frances M. Platt, Michael Leo Strupp, Antony Galione

This paper demonstrates that levacetylleucine modulates TFEB activity in a bidirectional manner, normalizing lysosomal function in both wild-type and NPC1 knockout cells.

bioRxiv · Dec 2, 2025 · PreprintPharmacology & Toxicology

Stereospecific rapid activation of Transcription Factor EB (TFEB) by Levacetylleucine (NALL)

Lianne C. Davis, Rebecca Brain, Grant C. Churchill, Mallory Factor, Taylor Fields, Frances M. Platt, Marc C. Patterson, Michael Leo Strupp, Antony Galione

This paper shows that NALL activates TFEB, enhancing lysosomal and autophagic function, which may explain its therapeutic effects in neurodegenerative diseases.

bioRxiv · Jun 6, 2025 · PreprintPharmacology & Toxicology